2022
DOI: 10.47391/jpma.4157
|View full text |Cite
|
Sign up to set email alerts
|

Mask-associated dry-eye in COVID-19 pandemic: a case report and review of the literature

Abstract: Mask-Associated Dry Eye (MADE) has been showing a rising trend during COVID 19 pandemic. This phenomenon seems inevitable, as wearing a face mask is a requisite part of personal protective measures to suppress of the spread of virus. However, simple expeditious awareness among health care staff, including the general population, can decrease the incidence. Keywords: Dry eye disease, COVID 19 Pandemic, Post-operative complications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“… 59 , 60 Nowadays, the highlights of clinical practice and research for anti-VEGF therapy are beyond the efficacy, and safety but the selection of the optimal treatment and the balance for health economics between the risks and benefits, for example, the prefer for ranibizumab or bevacizumab in neovascular AMD, 43 and the choices between aflibercept monotherapy or bevacizumab first in DME. 61 Third, with the high and increasing incidence, and the heavy disease burden of DED, MGD, and myopia, 27 , 62 , 63 , 64 , 65 , 66 especially the rapidly increasing of DED, MGD, and myopia related to more reliance on electronic screens and DED or MGD related to more reliance on the mask during the COVID-19 pandemic, 67 , 68 , 69 , 70 , 71 and with the novel therapies for myopia, DED, and MGD such as orthokeratology, atropine and botanical formula, 29 , 72 the requirement for high-quality evidence of interventions for DED, MGD and myopia has increased rapidly in recent years, which could explain in part the recent and future hotspots of DED, MGD and myopia in the field of worldwide ophthalmologic RCTs. Taken together, over the past two decades, anti-VEGF therapy for retinopathy such as AMD and DME, DED, the use of new ophthalmologic diagnostic tools, and myopic were the hottest research highlights.…”
Section: Discussionmentioning
confidence: 99%
“… 59 , 60 Nowadays, the highlights of clinical practice and research for anti-VEGF therapy are beyond the efficacy, and safety but the selection of the optimal treatment and the balance for health economics between the risks and benefits, for example, the prefer for ranibizumab or bevacizumab in neovascular AMD, 43 and the choices between aflibercept monotherapy or bevacizumab first in DME. 61 Third, with the high and increasing incidence, and the heavy disease burden of DED, MGD, and myopia, 27 , 62 , 63 , 64 , 65 , 66 especially the rapidly increasing of DED, MGD, and myopia related to more reliance on electronic screens and DED or MGD related to more reliance on the mask during the COVID-19 pandemic, 67 , 68 , 69 , 70 , 71 and with the novel therapies for myopia, DED, and MGD such as orthokeratology, atropine and botanical formula, 29 , 72 the requirement for high-quality evidence of interventions for DED, MGD and myopia has increased rapidly in recent years, which could explain in part the recent and future hotspots of DED, MGD and myopia in the field of worldwide ophthalmologic RCTs. Taken together, over the past two decades, anti-VEGF therapy for retinopathy such as AMD and DME, DED, the use of new ophthalmologic diagnostic tools, and myopic were the hottest research highlights.…”
Section: Discussionmentioning
confidence: 99%
“…The development and exacerbation of postoperative dry eye after cataract surgery is common and could be worsened with the use of face masks. A deterioration in corneal staining and an increase in dryness has been reported in cataract patients on their first postoperative day [ 3 , 72 ]. Patients with previous corneal surgery may be at higher risk.…”
Section: Effects Of Face Mask Use On Postoperative Patientsmentioning
confidence: 99%